source
- Recon: FDA identifies four deaths in Newron schizophrenia drug trials; Dutch court blocks subcutaneous Keytruda in eight Europea...Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 13d ago↗ source
- Dutch court orders Merck to halt subcutaneous Keytruda sales in eight European countriesA Dutch court has issued an injunction that requires Merck to stop manufacturing and selling the injectable, subcutaneous formulation of its cancer immunotherapy Keytruda in eight European countrie…